Gastroenterology, Hepatology, Nutrition

Mechanisms of Esophageal Inflammation, Remodeling and Firbosis in Eosinophilic Esophagitis
Principal Investigator: Barry Wershil, MD
Contact: Krista Tuzinkiewicz, Clinical Research Coordinator
Phone: 773-880-4354; 773-975-8523
Email: [email protected] / [email protected]
IRB Number: 2009-13869


Biliary Artesia Research Consortium 
Conditions: Biliary Atresia; Cholestasis Intervention
Principal Investigator:
Peter Whitington, MD
Co-Investigator: Riccardo Superina, MD
Email:
 
Phone: 773-880-4643
IRB Number: 2004-12283 (ClinicalTrials.gov Identifier: NCT00061828)

Biliary Atresia Study in Infants and Children 
Conditions: Biliary Atresia Intervention
Principal Investigator:
Peter Whitington, MD
Co-Investigator: Riccardo Superina, MD
Email:
 
Phone: 773-880-4643
IRB Number: 2006-12840 (ClinicalTrials.gov Identifier: NCT00345553)

Oral Viscous Budesonide Suspension (MB-7) in Subjects with Eosinophilic Esophagitis: A Randomized, Placebo-Controlled, Dose-Ranging Study in Children and Adolescents
Principal Investigator: Co-Investigator: Ameesh Shah, MD
Contact: Katie Jacques, Clinical Research Associate
Phone: 773-868-8009
Email:
/ IRB Number: 2009-13702  (www.thepeerstudy.com)
A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following Portoenterostomy 
Condition: Biliary Atresia
Interventions: Drug: Corticosteroids, Placebo
Principal Investigator:
Peter Whitington, MD
Co-Investigator: Riccardo Superina, MD
Phone: 773-880-4643
Email:

IRB Number: 2006-12840 (ClinicalTrials.gov Identifier: NCT00294684)

Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years 
Condition: Eosinophilic Esophagitis
Interventions: Biological: Reslizumab; Saline
Principal Investigator:
Ameesh Shah, MD
Contact: Ameesh Shah /Carol Ward
Phone: 773-880-4354 / 215-907-1330 ext 1091
Email:
 /
Clinical Trials.gov Identifier: NCT00538434
Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases 
Conditions: Liver Diseases; Alagille Syndrome; Alpha 1-Antitrypsin Deficiency
Principal Investigator:
Peter Whitington, MD
Contact: Krista Tuzinkiewicz/Susan M. Kelly, RN, BSN
Phone: 773-880-4643 / 773-975-8523 / 773-868-8931
Email:
/ /
Clinical Trials.gov Identifier: NCT00571272

A Multi-Center Group to Study Acute Liver Failure in Children 
Conditions: Acute Liver Failure; Hepatic Encephalopathy
Intervention: Drug: N-acetylcysteine
Principal Investigator:
Estella Alonso, MD
Phone: 773-880-4108
Email:

Clinicaltrials.gov Identifier: NCT00248625

 

Back to the top of the page